Raffles Medical Group

Raffles Medical leads; Tianjin Pharma, IHH Healthcare and Top Glove top own categories - THE EDGE SINGAPORE

Billion Dollar Club 2023

Raffles Medical leads; Tianjin Pharma, IHH Healthcare and Top Glove top own categories

Raffles Medical is expanding into new markets such as Vietnam

Broker's Calls

Maybank keeps 'buy' call and $1.65 target price on Raffles Medical following Vietnam and Changi deals

The Vietnam deal helps Raffles Medical diversify its business from beyond Singapore and China
Raffles Medical Group taking 'majority' stake in a Vietnam hospital valued at US$45.6 mil - THE EDGE SINGAPORE

Company in the news

Raffles Medical Group taking 'majority' stake in a Vietnam hospital valued at US$45.6 mil

As part of the agreement, RMG will also enter into a management service agreement to manage the AIH operations.
Raffles Medical's 1HFY2023 results likely to have set a new baseline of profitability, analysts keep 'buy' - THE EDGE SINGAPORE

Broker's Calls

Raffles Medical's 1HFY2023 results likely to have set a new baseline of profitability, analysts keep 'buy'

Raffles Medical is Maybank’s preferred pick in the healthcare sector.
Higher benchmark rates positive for healthcare service providers amid high inflation and increase in labour costs - THE EDGE SINGAPORE

Broker's Calls

Higher benchmark rates positive for healthcare service providers amid high inflation and increase in labour costs

The analysts expect longer term margins can be sustained following the MOH's updated benchmarks.
UOBKH ups Raffles Medical's TP as its transitional care facilities join Singapore's healthcare ecosystem - THE EDGE SINGAPORE

Broker's Calls

UOBKH ups Raffles Medical's TP as its transitional care facilities join Singapore's healthcare ecosystem

Raffles Medical Group boasts “healthy margins due to its asset-light nature”, say UOB Kay Hian Research analysts.
Analysts lift Raffles Medical Group's TPs following its 'exceptional year' - THE EDGE SINGAPORE

Broker's Calls

Analysts lift Raffles Medical Group's TPs following its 'exceptional year'

The analysts are now more positive on the prospects of RMG’s Chinese hospitals.
Analysts expect further upsides to Raffles Medical’s share price, maintain 'buy' - THE EDGE SINGAPORE

Broker's Calls

Analysts expect further upsides to Raffles Medical’s share price, maintain 'buy'

Maybank forecasts Raffles Medical to report slightly above consensus 2HFY2022 PATMI of $60 million.
×